41 completed, 12 unknown, 4 terminated, 2 active not recruiting. 23 Phase 4, 12 Not applicable, 11 Phase 3, 5 Early Phase 1, 4 Phase 2.
Follow ganirelix: new trials by email Literature Review of ganirelix trials Research Report on ganirelix
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oral GnRH Antagonist (Linzagolix) Versus Injectable GnRH Antagonist in Controlled Ovarian Stimulation for In Vitro Fertilization: A Randomized Controlled Non-Inferiority Trial With a Concurrent Comparator Cohort Undergoing Progestin-Primed Ovarian Stimulation (PPOS) Ganirelix ; Cetrorelix, Medroxyprogesterone Acetate ; Micronized Progesterone, Linzagolix - Infertility, Female, Ovulation Induction | Not applicable | Not yet recruiting | Centro A.M.B.R.A. (Associazione Medici e Biologi per la Riproduzione Assistita) | 120 | 2026-09-01 | 2026-09-30 |
| PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over Study Elonva®, Puregon®, Orgalutran® - Ovarian Stimulation, Quality of Life | Phase 4 | Recruiting | University Hospital, Ghent | 60 | 2025-01-27 | 2025-12-26 |
| Disentangling the Effects of Daily Stress, Sleep, and Sex Hormones on Accelerated Vascular Aging in Midlife Women ganirelix acetate - Estrogen, Premenopause | Phase 4 | Recruiting | University of Delaware | 30 | 2024-11-15 | 2026-07-02 |
| Protocol with Progestin-primed Ovarian Stimulation (PPOS) from the Beginning of Stimulation Versus Protocol with GnRH Antagonists for Ovarian Stimulation in Patients Undergoing DUOSTIM with Embryo Accumulation for PGT-A. Ganirelix, Medroxyprogesterone Acetate 10 MG - Stimulation in the Ovary, Embryo | Phase 4 | Unknown | Ginefiv | 144 | 2024-10-15 | 2024-10-15 |
| Possible Action of Resveratrol in Improving the Outcomes of IVF/ICSI in Couples With Unexplained Infertility Resveratrol-based multivitamin supplement, Folic acid, IVF/ICSI - Unexplained Infertility | Not applicable | Unknown | Andros Day Surgery Clinic | 90 | 2024-06-01 | 2024-07-01 |
| Sub-therapeutic GnRH- Antagonist Treatment to Rectify LH Pulsatility in Lean Women With PCOS. Ganirelix - Polycystic Ovary Syndrome | Early Phase 1 | Completed | University Hospital, Lille | 20 | 2024-04-17 | 2025-04-27 |
| Efficacy of Micronized Natural Progesterone vs GnRH Antagonist in the Prevention of LH Peak During Ovarian Stimulation. Progesterone 200 MG, Ganirelix Acetate - IVF | Phase 4 | Completed | Instituto Bernabeu | 150 | 2023-12-23 | 2026-03-27 |
| To Investigate Efficacy and Safety of a Single Injection of GenSci094 for Ovarian Stimulation Using Daily Recombinant FSH as Reference GenSci094, Placebo RecFSH / follitropin alfa, Biological: RecFSH / Follitropin alfa (Days 1 to 7) - Infertility | Phase 3 | Completed | Changchun GeneScience Pharmaceutical Co., Ltd. | 176 | 2023-03-24 | 2024-12-03 |
| GnRH Antagonist Pre-treatment for the Prevention of Asynchronous Follicular Growth Ganirelix Acetate, Cetrolix Acetate - IVF | Phase 4 | Unknown | Assaf-Harofeh Medical Center | 15 | 2021-04-01 | 2021-10-08 |
| Desogestrel Versus GnRH Antagonist in IVF/ICSI Desogestrel 0.075 MG, Orgalutran - IVF, Infertility | Phase 4 | Unknown | Casa di Cura Privata Villa Mafalda | 165 | 2020-10-01 | 2021-01-28 |
| The Rate of Embryo Euploidy in Progestin-primed Ovarian Stimulation Cycles Medroxyprogesterone Acetate, Ganirelix Acetate - IVF, Infertility | Phase 4 | Unknown | Casa di Cura Privata Villa Mafalda | 396 | 2020-09-01 | 2020-12-04 |
| Live Birth Rate Between PPOS and GnRH Antagonist Protocol in Patients With Anticipated High Ovarian Response Progesterone, GnRH Antagonist - IVF, GnRH Antagonist | Phase 3 | Completed | ShangHai Ji Ai Genetics & IVF Institute | 784 | 2020-06-04 | 2023-08-30 |
| Hormonal Mechanisms of Sleep Restriction - Axis Study in Older Men and Postmenopausal Women Ketoconazole Pill (also known as nizoral), Ganirelix, Dexamethasone Pill - Sleep Restriction | Early Phase 1 | Active not recruiting | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | 5 | 2020-02-09 | 2025-09-11 |
| Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles. GnRh antagonist, Micronized progesterone - Infertility, IVF | Not applicable | Completed | Fundacion Dexeus | 44 | 2019-09-25 | 2023-05-15 |
| DuoStim in Cases of PGT: Comparison of Embryo Quantity and Embryonic Quality Using MitoScore human menopausal gonadotropin, GnRH antagonist, GnRH analog - Infertility, Female | Not applicable | Completed | IVI Madrid | 136 | 2017-12-01 | 2020-12-29 |
| Mechanisms of Hypertension in Women With Polycystic Ovary Syndrome GnRH antagonist, GnRH antagonist + MethylTESTOSTERone 5 MG - Polycystic Ovary Syndrome, Hypertension | Early Phase 1 | Terminated | Yale University | 28 | 2017-12-01 | 2024-02-02 |
| Effectiveness of Estradiol Valerate Pretreatment in Antagonist Protocol for Poor Ovarian Response Patient Follitropin Beta;MSD, Ganirelix, hCG - Infertility | Not applicable | Completed | Reproductive & Genetic Hospital of CITIC-Xiangya | 552 | 2017-11-15 | 2022-01-11 |
| Cetrorelix and Ganirelix Flexible Protocol for (IVF) Ganirelix Acetate, Cetrorelix Acetate - Infertility/Sterility | Phase 4 | Unknown | Università degli Studi 'G. d'Annunzio' Chieti e Pescara | 100 | 2017-11-15 | 2018-03-27 |
| Usefulness of Medroxyprogesterone Acetate in Follicular Phase in Oocyte Donors. Undergoing Ovarian Stimulation Provera 10 mg., Ganirelix (GnRH antagonist) - Infertility | Phase 3 | Completed | Instituto Valenciano de Infertilidad, IVI VALENCIA | 318 | 2017-10-20 | 2021-08-25 |
| Hormonal Mechanisms of Sleep Restriction - Axis Study Ketoconazole Pill, Ganirelix, Dexamethasone - Sleep Restriction | Phase 1 | Active not recruiting | Peter y. Liu | 80 | 2017-05-08 | 2025-09-11 |
Showing 20 of 64. Sign in to see all of them.
Infertility (29) · Polycystic Ovary Syndrome (4) · Congenital Abnormalities (2) · Infertility, Female (2) · Primary Ovarian Insufficiency (2) · Aneuploidy (1) · Helping Behavior (1) · Hypertension (1) · Obesity (1) · Orthostatic Intolerance (1) · Ovarian Hyperstimulation Syndrome (1) · Puberty, Delayed (1) · Puberty, Precocious (1)
Organon and Co (10) · Eugonia (4) · Yale University (4) · Casa di Cura Privata Villa Mafalda (2) · Fundacion Dexeus (2) · IVI Madrid (2) · Universitair Ziekenhuis Brussel (2) · Yazd Research & Clinical Center for Infertility (2) · Andros Day Surgery Clinic (1) · Assaf-Harofeh Medical Center (1) · Bart CJM Fauser (1) · Centro A.M.B.R.A. (Associazione Medici e Biologi per la Riproduzione Assistita) (1) · Centro Ginecologia y Obstetricia. (1) · Changchun GeneScience Pharmaceutical Co., Ltd. (1) · Chong Qing Reproducive and Genetic Institute (1)
United States (17) · Spain (9) · Italy (5) · Belgium (4) · Greece (4) · China (3) · Iran (2) · Israel (2) · Netherlands (2) · France (1) · Germany (1) · Norway (1) · South Korea (1) · Vietnam (1)
Nina Stachenfeld, PhD (4) · Tryfon Lainas, PhD (4) · Peter Liu, MD, PhD (2) · Adolfo Allegra, MD (1) · Bart C Fauser, Prof, PhD (1) · Carol M Foster, MD (1) · Eduardo Kelly, MD, MBA (1) · Fei Gong, Doctor (1) · Ghassan F Haddad, M.D. (1) · Gian Mario Tiboni, professor (1) · Hong Ye, bachelor (1) · Jody Greaney, PhD (1)
PMID 22459628, PMID 26950065, PMID 26991902, PMID 42294856, PMID 15126522, PMID 17222700, PMID 18403419, PMID 19684043, PMID 20008886, PMID 20378616, PMID 20483664, PMID 20843746, PMID 22429192, PMID 22587997, PMID 22969140, PMID 23758821, PMID 24903202, PMID 25154677, PMID 26315293, PMID 27619773, PMID 28755171, PMID 29040589, PMID 30927417, PMID 33487442, PMID 33814126, PMID 33934703, PMID 34338114, PMID 35460400, PMID 36483694, PMID 37599566, PMID 38272383, PMID 38498835, PMID 38577571
2004 (3), 2023 (3), M01RR000064 (1), R01AG027678 (1), R01HL071159 (1), R01HL135089 (1), R21AG090810 (1), R21HL093450 (1)